Literature DB >> 30502235

Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model.

Yoshihisa Makino1, Takuya Miyahara2, Jun Nitta1, Kazuhiro Miyahara1, Akihiko Seo1, Masaru Kimura1, Masamitsu Suhara1, Atsushi Akai1, Daisuke Akagi1, Kota Yamamoto1, Katsuyuki Hoshina1.   

Abstract

BACKGROUND: Specialized proresolving mediators from ω-3 polyunsaturated fatty acid may control resolution of inflammation. We evaluated the influence of two specialized proresolving mediators, resolvin D1 (RvD1) and protectin D1 isomer (PD1 iso) on neointimal hyperplasia after balloon injury.
MATERIALS AND METHODS: Sprague Dawley male rats at 12-14 wk of age were injured as a model of balloon angioplasty. Then, 1 μg/rat of RvD1 or PD1 iso was administered intravenously via the tail vein immediately and 2 d after angioplasty. The proliferation of injured artery and the infiltration of leukocytes, monocytes, and macrophages at 3 d after injury were evaluated by immunostaining. The activity of the inflammatory transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) in the injured artery at 3 d after injury was evaluated using an enzyme-linked immuno sorbent assay kit. The proliferation of the neointima was evaluated by calculating the ratio of the neointimal and medial areas using specimens at 14 d after injury.
RESULTS: RvD1 and PD1 iso attenuated proliferation of medial cells (P < 0.05) and infiltration of leukocytes (P < 0.05) and monocytes/macrophages (P < 0.01). Although both RvD1 and PD1 iso mitigated NFκB activity (P < 0.01), RvD1 attenuated this activity more strongly (P < 0.01). RvD1 decreased neointimal hyperplasia by 37.3% (P < 0.01), whereas PD1 iso decreased neointimal hyperplasia by 31.8% (P < 0.05) (RvD1 versus PD1 iso: P = 0.51).
CONCLUSIONS: RvD1 and PD1 iso reduced the activity of inflammatory transcription factor NFκB within the injured artery and attenuated inflammatory cell infiltration, leading to a reduction in early inflammation and subsequent neointimal hyperplasia.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Inflammation; Neointimal hyperplasia; Protectin D1 isomer; Resolvin D1; ω-3 fatty acid

Mesh:

Substances:

Year:  2018        PMID: 30502235     DOI: 10.1016/j.jss.2018.07.049

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.

Authors:  Mohan Satish; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2019-01-09

2.  Plasma Lipid Mediators Associate With Clinical Outcome After Successful Endovascular Thrombectomy in Patients With Acute Ischemic Stroke.

Authors:  Jiheng Hao; Yao Feng; Xin Xu; Long Li; Kun Yang; Gaolei Dai; Weiwei Gao; Meng Zhang; Yaming Fan; Tengkun Yin; Jiyue Wang; Bin Yang; Liqun Jiao; Liyong Zhang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

3.  An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study.

Authors:  Yuzhu Wang; Junjie Li; Indhumathy Subramaniyan; Goncalo Dias do Vale; Jaideep Chaudhary; Arnida Anwar; Mary Wight-Carter; Jeffrey G McDonald; William C Putnam; Tao Qin; Hongwei Zhang; Ian R Corbin
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-15       Impact factor: 4.219

Review 4.  Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration.

Authors:  Aaron H Wasserman; Manigandan Venkatesan; Aitor Aguirre
Journal:  Cells       Date:  2020-06-03       Impact factor: 6.600

Review 5.  The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification.

Authors:  Miguel Carracedo; Gonzalo Artiach; Hildur Arnardottir; Magnus Bäck
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

6.  Protectin DX restores Treg/Th17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a.

Authors:  Shengwei Jin; Siyuan Sun; Hanzhi Ling; Jinglan Ma; Xu Zhang; Zhen Xie; Ning Zhan; Wenjie Zheng; Man Li; Yang Qin; Heping Zhao; Yan Chen; Xinyu Yang; Jianguang Wang
Journal:  Cell Death Dis       Date:  2021-03-15       Impact factor: 8.469

Review 7.  Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.

Authors:  Lucía Serrano Díaz Del Campo; Raquel Rodrigues-Díez; Mercedes Salaices; Ana M Briones; Ana B García-Redondo
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

8.  Light sheet fluorescence microscopy as a new method for unbiased three-dimensional analysis of vascular injury.

Authors:  Nicholas E Buglak; Jennifer Lucitti; Pablo Ariel; Sophie Maiocchi; Francis J Miller; Edward S M Bahnson
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

Review 9.  Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.

Authors:  Juan Salazar; Daniela Pirela; Manuel Nava; Ana Castro; Lissé Angarita; Heliana Parra; Samuel Durán-Agüero; Diana Marcela Rojas-Gómez; Néstor Galbán; Roberto Añez; Maricarmen Chacín; Andrea Diaz; Nelson Villasmil; Juan Bautista De Sanctis; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.